Medibiofarma, S.L.

BiotechnologySeedNavarra, Spainmedibiofarma.com

Latest round

Seed

Last raised

Mar 2022

Total raised

$1.3M

Investors

3

About Medibiofarma, S.L.

L. operates as a biotechnology research company developing drugs and therapies for the treatment of cancer. The clinical stage biotechnology company engages in research programs, based on the modulation of clinically validated therapeutic targets, providing disease-modifying treatments for conditions such as cancer, cognitive decline, and fibrosis. Medibiofarma mainly focuses on discovering and developing new chemical entities (NCEs) with clinical proof-of-concept data in human patients. The company strategically allocates internal resources to key areas such as drug design, medicinal and synthetic chemistry, in vitro pharmacology, intellectual property, clinical trials, and business development. Notable among its pipeline is MBF-118, a covalent partial agonist of the PPAR? nuclear receptor, a therapy for fibrosis in Crohn's disease. Additionally, Medibiofarma's portfolio includes MBF-362, an EP4 receptor antagonist for cancer immunotherapy, MBF-015, a histone deacetylase inhibitor targeting synaptic loss in neurodegenerative diseases, and MBF-132, a selective histone deacetylase 8 inhibitor for fibrosis treatment.

Who invested in Medibiofarma, S.L.

3 investors across 1 round

See all investors in Medibiofarma, S.L.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Mar 15, 2022

    Amount

    $1.3M

    Investors

    Locked

Questions about Medibiofarma, S.L.

Who invested in Medibiofarma, S.L.?

Medibiofarma, S.L. has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Medibiofarma, S.L. raised?

Medibiofarma, S.L. has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Medibiofarma, S.L. last raise money?

Medibiofarma, S.L.'s most recent round on record is a Seed, in Mar 2022.

What does Medibiofarma, S.L. do?

Medibiofarma, S.L. is a biotechnology company.

Where is Medibiofarma, S.L. headquartered?

Medibiofarma, S.L. is headquartered in Navarra, Spain.

Which VCs invest in companies like Medibiofarma, S.L.?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Medibiofarma, S.L.'s stage. Their profiles are linked below.

Raising like Medibiofarma, S.L.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.